Company Overview
Snapshot
Founded in August 2009 by Yohai Golan-Gild, Better operates with 11–50 employees. The company has raised $15 million across one funding round. In February 2022, InterCure signed a definitive agreement to acquire Better.
Business overview
Better specializes in the development of medical-grade cannabis for various medical conditions, focusing on strains with diverse CBD and THC combinations and high terpene levels to enhance product efficiency and potency. The company offers a range of standardized, contaminant-free products with consistent active pharmaceutical ingredients, including THC, CBD, and other cannabinoids. Better serves the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis, targeting patients globally.
Strategic signal
The definitive agreement for InterCure to acquire Better, signed in February 2022, signals a significant consolidation within the medical cannabis industry. This acquisition provides InterCure with Better's multi-national production capabilities and specialized strains, indicating a strategic move towards market expansion and enhanced product offerings. For investors, this suggests a potential for increased market share and operational synergies within the acquiring entity, validating Better's product development and market position.
Company Intelligence Q&A
- What was a significant corporate development for Better in early 2022?
- In February 2022, InterCure signed a definitive agreement to acquire Better, a multi-national medical cannabis producer.
- What strategic intent did Better Holdings express in October 2019?
- In October 2019, Cannabis Company Better Holdings expressed an intent to sell its Israeli operations.
- What research initiative involving medical cannabis was trialled in June 2016?
- In June 2016, medical cannabis was trialled in the treatment of melanoma at the University of Canberra.
- Who is a key founder of Better and what was their contribution to medical marijuana research?
- Yohai Gild Golan, a founder of Better, was noted in September 2016 for advancing medicinal marijuana research in Israel.